Home About us Contact
|
Home About us Contact | ||
|
|
||
Potential Inhibition (potential + inhibition)
Selected AbstractsResponse of Listeria monocytogenes to liquid smokeJOURNAL OF APPLIED MICROBIOLOGY, Issue 6 2008M. Guilbaud Abstract Aims:, To investigate the effect of liquid smoke on growth, survival, proteomic pattern and haemolytic potential of Listeria monocytogenes. Methods and Results:, Growth and survival curves were recorded in brain,heart infusion broth supplemented with three concentrations of liquid smoke. L. monocytogenes growth was inhibited in the presence of 15 ,g ml,1 phenol while a rapid decrease in cell viability occurred in the presence of 30 ,g ml,1 phenol. The proteome of L. monocytogenes cytosoluble proteins was slightly modified after 2-h incubation with 30 ,g ml,1 phenol but no protein already characterized in response to other known stresses was induced, except the protease ClpP. Liquid smoke inhibited the haemolytic potential without affecting hly gene expression, showing a potential inhibition of protein activity or stability. Conclusions:, The presence of liquid smoke in a rich medium strongly affected growth and survival of L. monocytogenes. Brief smoke stress affected the metabolic pathways and inhibited the haemolytic activity of L. monocytogenes. Significance and Impact of Study:, This study is a first step in the investigation of the influence of a smoked product on L. monocytogenes strains. [source] Internal amplification controls have not been employed in fungal PCR hence potential false negative resultsJOURNAL OF APPLIED MICROBIOLOGY, Issue 1 2007R.R.M. Paterson Abstract Polymerase chain reaction (PCR) is subject to false negative results. Samples of fungi with the genes of interest (e.g. a disease or mycotoxin) may be categorized as negative and safe as a consequence. Fungi are eukaryotic organisms that are involved in many fields of human activity such as antibiotic, toxin and food production. Certain taxa are implicated in human, animal and plant diseases. However, fungi are difficult to identify and PCR techniques have been proposed increasingly for this purpose. Internal amplification controls (IACs) will ameliorate the situation and need to become mandatory. These are nucleic acids that posses a sequence which will provide a PCR product (i) using the same primers employed for the target gene, and (ii) that will not coincide on the gel with the product of the target gene. Only one group of workers employed an IAC, to respond to potential inhibition, which was reported in 1995 from this present assessment of numerous reports. Inhibitors in cultures need to be minimized, and secondary metabolites are an obvious source. The fields reviewed herein include medical mycology, mycotoxicology, environmental mycology and plant mycology. The conclusion is that previous reports are compromised because IACs have not been employed in fungal PCR; future research must include this control at an early stage. [source] Blood,brain barrier efflux transportJOURNAL OF PHARMACEUTICAL SCIENCES, Issue 9 2003Pamela L. Golden Abstract Efflux transport at the blood,brain barrier (BBB) limits the brain tissue exposure to a variety of potential therapeutic agents, including compounds that are relatively lipophilic and would be predicted to permeate the endothelial lining of the brain microvasculature. Recent advances in molecular and cell biology have led to identification of several specific transport systems at the blood,brain interface. Refinement of classical pharmacokinetic experimentation has allowed assessment of the structural specificity of transporters, the impact of efflux transport on brain tissue exposure, and the potential for drug,drug interactions at the level of BBB efflux transport. The objective of this minireview is to summarize efflux transporter characteristics (location, specificity, and potential inhibition) for transport systems identified in the BBB. A variety of experimental approaches available to ascertain or predict the impact of efflux transport on net brain tissue uptake of substrates also are presented. The potential impact of efflux transport on the pharmacodynamics of agents acting in the central nervous system are illustrated. Finally, general issues regarding the role of identifying efflux transport as part of the drug development process are discussed. © 2003 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 92:1739,1753, 2003 [source] Collision-induced dissociation of protonated tetrapeptides containing , -alanine, , -aminobutyric acid, , -aminocaproic acid or 4-aminomethylbenzoic acid residues,RAPID COMMUNICATIONS IN MASS SPECTROMETRY, Issue 22 2006Erach R. Talaty The influence of the presence and position of a single , -alanine, , -aminobutyric acid, , -aminocaproic acid or 4-aminomethylbenzoic acid residue on the tendency to form b - and y -type product ions was determined using a group of protonated tetrapeptides with general sequence XAAG, AXAG and AAXG (where X refers to the position of amino acid substitution). The hypothesis tested was that the ,alternative' amino acids would influence product ion signal intensities by inhibiting or suppressing either the nucleophilic attack or key proton transfer steps by forcing the adoption of large cyclic intermediates or blocking cyclization altogether. We found that specific b ions are diminished or eliminated completely when ,A, ,Abu, Cap or 4AMBz residues are positioned such that they should interfere with the intramolecular nucleophilic attack step. In addition, differences in the relative proton affinities of the alternative amino acids influence the competition between complementary bn and yn ions. For both the AXAG and the XAAG series of peptides, collision-induced dissociation (CID) generated prominent b ions despite potential inhibition or suppression of intramolecular proton migration by the ,A, ,Abu, Cap or 4AMBz residues. The prominent appearance of b ions from the AXAG and XAAG peptide is noteworthy, and suggests either that proton migration occurs through larger, ,whole' peptide cyclic intermediates or that fragmentation proceeds through a population of [M+H]+ isomers that are initially protonated at amide O atoms. Copyright © 2006 John Wiley & Sons, Ltd. [source] Enhanced anaerobic bioremediation in a multicontaminant plumeREMEDIATION, Issue 2 2008Julie S. Konzuk The potential application of enhanced in situ bioremediation (EISB) for treatment of a plume containing high concentrations of 1,2-dichloroethane (1,2-DCA), as well as lower concentrations of other chlorinated ethanes, chlorinated methanes, and chlorinated ethenes was evaluated through the implementation of four field trials. The field trials confirmed that EISB is an effective technology for treating multiple contaminants, with estimated mass removal rates on the order of several kilograms per day and groundwater concentration reductions nearing 100 percent of the initial concentrations. The field trials also demonstrated that engineering controls could be effectively used to overcome potential inhibitions related to high concentrations of 1,2-DCA. © 2008 Wiley Periodicals, Inc. [source] | ||||||||||